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INVESTIGATION
Expanding CRISPR/Cas9 Genome Editing Capacity
in Zebrafish Using SaCas9
Yan Feng,* Cheng Chen,* Yuxiang Han,* Zelin Chen,*,† Xiaochan Lu,* Fang Liang,* Song Li,* Wei Qin,*,1
and Shuo Lin*,†,1
*Laboratory of Chemical Genomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen
Graduate School, 518055, China, and †Department of Molecular, Cell and Developmental Biology, University of
California, Los Angeles, California 90095
ABSTRACT The type II CRISPR/Cas9 system has been used widely for genome editing in zebrafish.
However, the requirement for the 59-NGG-39 protospacer-adjacent motif (PAM) of Cas9 from Streptococcus
pyogenes (SpCas9) limits its targeting sequences. Here, we report that a Cas9 ortholog from Staphylococ-
cus aureus (SaCas9), and its KKH variant, successfully induced targeted mutagenesis with high frequency in
zebrafish. Confirming previous findings, the SpCas9 variant, VQR, can also induce targeted mutations in
zebrafish. Bioinformatics analysis of these new Cas targets suggests that the number of available target sites
in the zebrafish genome can be greatly expanded. Collectively, the expanded target repertoire of Cas9 in
zebrafish should further facilitate the utility of this organism for genetic studies of vertebrate biology.
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Targetedgenomeengineeringoffersnewgenetic tools forunderstanding
biological processes, and for developing therapeutics of human dis-
eases. Following the development of Zinc Finger (ZFs) and transcrip-
tion activator-like effector (TALEs) technology (Doyon et al. 2008;
Huang et al. 2011; Meng et al. 2008), the clustered regularly inter-
spaced short palindromic repeat/CRISPR-associated (CRISPR/Cas)
system has emerged as the current gene editing tool of choice.
CRISPR/Cas system has the advantages of ease of handling, low cost,
and universal applicability in different cell types and organisms.
CRISPR/Cas can be classified into six types based on the presence
of ‘‘signature genes’’ (Makarova et al. 2011, 2015; Shmakov et al.
2015; Wright et al. 2016). Among them, Cas9 from Streptococcus
pyogenes (SpCas9), which belongs to the type II CRISPR/Cas system,
has been demonstrated to be effective in inducing targeted DNA
double strand breaks (DSBs) in a variety of organisms (Chang et al.
2013; Cong et al. 2013; Dickinson et al. 2013; Friedland et al. 2013;
Gratz et al. 2013; Hwang et al. 2013; Jinek et al. 2013; Mali et al. 2013;
Qin et al. 2015; Shalem et al. 2014; Wang et al. 2014; Yang et al.
2013a). SpCas9 nuclease DNA sequence specificity relies on a guide
RNA with a protospacer-adjacent motif (PAM) sequence at the 39
end of a 20-bp target sequence. The most widely used SpCas9 recog-
nizes a short 59-NGG-39 PAM. Since PAM sequences are different in
different CRISPR/Cas systems, alternative PAMs would provide more
flexibility for targeting strategies such as precise knock-in mutations.
Recently, Cas9 orthologs with distinct DNA binding specificity and
PAM recognition, including Neisseria meningitidis (NmCas9), Strepto-
coccus thermophilus1 (St1Cas9), and Staphylococcus aureus (SaCas9)
have been applied for genome editing in human cells (Hou et al. 2013;
Karvelis et al. 2013; Ran et al. 2015). Among them, Cas9 from S. aureus
(SaCas9) is smaller, and has a longer PAMof 59-NNGRRT-39sequence.
These features allow easier deliver by viral expression vectors, and
higher sequence specificity, which would be more desirable for ther-
apeutic applications. Recently, a SaCas9 variant (KKH SaCas9)
with partially relaxed 59-NNNRRT-39 PAM specificities has been
demonstrated to show robust genome editing activities in human
cells, which further increases the SaCas9 targeting range (Kleinstiver
et al. 2015a).
Here, we demonstrate that SaCas9, with itsKKHSaCas9 variant, can
edit the zebrafish genome with high targeting efficiency. This increases
the frequency of available target sites, and expands the utility of
CRISPR/Cas9 in zebrafish by targeting those previously inaccessible
Cas9 sites in the genome.
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Figure 1 Gene disruption by SaCas9. (A) Schematic representation of the CRISPR/SaCas9 system, including SaCas9 and the gRNA.
SaCas9 flanked by two NLS signals is driven by SP6 promoter, and the gRNA is driven by T7 promoter. The PAM is highlighted in red.
The target site is labeled by blue color. (B) Phenotype of embryos by targeting the tyr gene. Scale bar = 500 mm. (C) Phenotype of
embryos by targeting the EGFP transgene. Scale bar = 500 mm. (D-E) Sequencing results at the tyr and EGFP targets. Target sequence
(blue), PAM region (red), deletion (red dashes) and insertions (lower case letters in green) are indicated. The numbers of mutant alleles
are indicated in [·] brackets.
2518 | Y. Feng et al.
MATERIALS AND METHODS
Zebrafish husbandry and breeding
Wild typeTufish and tg(mylpfa:EGFP) transgenicfish strainswere raised
andmaintained at 28.5 in a circulating system. Zebrafish embryos were
acquired from in-tank breeding. Development of embryos was staged
by standard morphological criteria (Kimmel et al. 1995). All zebrafish
experiments were approved by the Institutional Animal Care and Use
Committee (IACUC) of Peking University. The reference from IACUC
of Peking University is LSC-ZhangB-1.
Plasmid construction and RNA synthesis
The full-length humanized NLS-SaCas9-NLS product was cloned from
plasmid(Addgene#61591), andsubcloned into thepCS2+vector.pX601-
AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA;U6::BsaI-sgRNA was a
gift from Feng Zhang. SaCas9 and SpCas9 variant VQR were mutated
on the basis of NLS-SaCas9-NLS and pT7-nls-zCas9-nls plasmids (Liu
et al. 2014), respectively, using VazymeMut Express II FastMutagenesis
Kit V2. After linearization by either NotI (pCS2-nls-hSaCas9-nls) or
XbaI (pT7-nls-zCas9-nls), capped mRNA was synthesized using a
mMESSAGEmMACHINE Sp6 or T7 kit, and purified using an RNeasy
FFPE kit (Qiagen). All gRNAs templates in this study were prepared
according to the cloning-independent gRNAgenerationmethod, and all
sites are listed in Supplemental Material, Table S1 (Bassett et al. 2013).
gRNAswere transcribed in vitro using the T7MAXIscript Kit (Ambion),
and purified using an RNeasy FFPE kit (Qiagen). Table S2 lists all the
oligos used in this study.
Zebrafish microinjection, T7EI assays, and
Sanger sequencing
A solution (1–2 nl) containing Cas9 mRNA (300 ng/ml) and gRNA
(30 ng/ml) was coinjected into one-cell-stage zebrafish embryos. In-
jected embryos were incubated at 28.5 for examination of phenotypes.
After 2 d post fertilization (dpf), embryos that developed normally
were collected for genotyping. GenomicDNAwas extracted from pools
of six randomly collected embryos by alkaline lysis buffer-based DNA
extraction. Targeted genomic loci were amplified from genomic DNA,
and then cloned into the pEASY-T1 vector (Transgene) for sequencing.
T7E1 assays were performed as previously described for zebrafish
(Hwang et al. 2013). The digested samples were analyzed through a
2% agarose gel. Quantification was based on relative band intensity
using Quantity One software (Bio-Rad). All experiments were repeated
three times.
Imaging
Zebrafish embryos were anesthetized with 0.03% Tricaine (Sigma-
Aldrich), and mounted in 4%methylcellulose. Photographs were taken
by a Zeiss Axio Imager Z1 microscope, and processed by Adobe
Photoshop CC software.
Annotation of CRISPR target sites in coding exons
We searched for all potential CRISPR target sites of NGG, NGA,
NNGRRN, NNGRRT, NNNRRN, and NNNRRT on both strands of
the zebrafish genome (danRer10), and marked their chromosomal
positions. Then, we produced a BED file to show all these PAM sites
in exons as annotated by the UCSC browser.
Data availability
The authors state that all data necessary for confirming the conclusions
presented in the article are represented fully within the article.
RESULTS AND DISCUSSION
Gene editing in zebrafish using SaCas9
First, we engineered SaCas9 to contain a NLS sequence in the pCS2+
expression vector, and used a simple one-step cloning-free PCRmethod
to generate gRNA template for RNA transcription in vitro (Figure 1A)
Figure 2 KKH SaCas9- and VQR
SpCas9-mediated genome editing
in zebrafish. (A) PAM-interacting
domain for KKH SaCas9 and VQR
SpCas9 in amino acid sequence
comparison with SaCas9 and
SpCas9, respectively. Variable
amino acid residues are high-
lighted in red. (B) Activity of
KKH SaCas9 and VQR SpCas9
targeting zebrafish endogenous
genes. Quantification is based
on T7E1 assay. Error bars repre-
sent SEM, n = 6 embryos. Se-
quencing data of these targeted
indels is included in Figure S2.
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(Bassett et al. 2013). Although SaCas9 can target all 59-NNGRR-39
PAMs, it cleaves the sequence of 59-NNGRRT-39 most efficiently
(Ran et al 2015). We therefore selected this type of PAM sequence
from the zebrafish genome for initial testing. Since pigmentation defect
is a convenient phenotype indication for mutation in the tyrosinase
(tyr) gene, which encodes an enzyme that converts tyrosine into
melanin (Camp and Lardelli 2001), we designed a gRNA targeting
tyr. After coinjection of tyr gRNA and SaCas9 mRNA into one-cell-
stage zebrafish embryos, pigmentation reduction was observed in
42 embryos (n = 73), some of which totally lacked pigmentation
(Figure 1B). Injected embryos developed normally, no obvious tox-
icity was observed. We randomly selected six embryos, extracted
genomic DNA from pools of embryos and assessed the mutagenesis
rates using the T7 endonuclease I (T7EI) assay and further con-
firmed indels at the expected sites by sequencing (Figure 1D).
To test if SaCas9/gRNA can be used generally in zebrafish, we
constructed eight additional gRNAs, one targeting transgene EGFP
and others targeting endogenous genes. When EGFP SaCas9/gRNA
was injected into tg (mylpfa:EGFP) zebrafish eggs, loss of EGFP
expression was observed in muscle cells (Figure 1C). For other
specific sites, indels were detected in all injected embryos with a
frequency of 13–76%. Again, the indels were sequencing confirmed
at the expected genomic loci (Figure 1E and Figure S1). Taken
together, these results demonstrate that SaCas9 can effectively edit
genome in zebrafish.
Gene editing in zebrafish using KKH SaCas9
Native SaCas9 recognizes a longer 59-NNGRRT-39 PAM, which occurs
on average every 32 bps of random DNA. Obtaining variants with
relaxed or partially relaxed specificity to expand the repertoire of gene
editing tools in zebrafish is desirable. Toward this goal, we investigated
two recently described SaCas9 and SpCas9 variants with different spec-
ificities (Figure 2A) (Kleinstiver et al. 2015a, 2015b). One SaCas9 var-
iant is called KKH SaCas9, which can target 59-NNNRRT-39 PAM in
human genome (Kleinstiver et al. 2015a). We evaluated the activity of
KKH SaCas9 by targeting four endogenous genes in zebrafish, and
observed indels in all of them (Figure 2B and Figure S2). Similarly,
we evaluated activity of the SpCas9 VQR variant with an NGA PAM,
which has been shown previously to induce indels in zebrafish
and Caenorhabditis elegans (Bell et al. 2016; Kleinstiver et al. 2015b),
and obtained expected indels at the two predicted sites (Figure 2B and
Figure S2). Collectively, these results demonstrate that both KKH
SaCas9 and VQR SpCas9 variants are functional in zebrafish. Since
59-NNNRRT-39 represents a relaxed PAM, it is conceivable that the
off-target rate might be increased. In zebrafish, this potential problem
could be addressed by analyzing the linkage between the targeted
mutation, and the specific phenotype in large numbers of individual
fish through breeding multiple generations.
The SpCas9 system is an efficient tool for genome editing in many
organisms including bacteria, yeast, human cells, C. elegans, zebrafish,
and mice (Hsu et al. 2014; Sternberg and Doudna 2015). Due to the
restriction of having to use the 59-NGG-39 PAM required by SpCas9, it
is challenging to find target sites with high efficiency in a specific
genome locus. Improving the capacity to target very specific loci is
highly desirable for DNAhomology-directed gene repair, which ismost
efficient when a DSB is placed within 10–20 bp of a desired alteration
(Elliott et al. 1998; Findlay et al 2014; Yang et al. 2013b). Here, we
demonstrate that using SaCas9 and its variant enable genome editing in
a significantly wider range in zebrafish. Since Cas9-based gene editing is
most commonly applied to induce or repair mutations in coding exons
of a gene, we produced a BED file to annotate six types of target sites
(NGG, NGA,NNGRRN,NNGRRT, NNNRRN, andNNNRRT) on the
UCSC gene browser.
One of the key issues in usingCRISPR/Cas9 system successfully is to
assure high activity. First, similar to the zebrafish-codon-optimized
SpCas9, which increases gRNA targeting efficiency from 4% to
39% (Liu et al. 2014), we recommend constructing a zebrafish
codon-optimized SaCas9 for future study. Second, it is also possible
that direct SaCas9 protein injections could further increase efficiency
(Burger et al. 2016; Gagnon et al. 2014). Finally, as modifying the
SpCas9/gRNA structure by extending the duplex length has been
shown to improve knockout efficiency (Dang et al. 2015), we speculate
that the same strategy could be applied to SaCas9/gRNA structure in
zebrafish.
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